This website uses cookies to enhance the user experience.
21st logo
||
K

KARDIOKONSULT AS957 207 529

Mental health
Limited company
Vesterøyveien 48 3235 SANDEFJORD, Norge

KARDIOKONSULT AS

Operating
Drive spesialistlegepraksis. Forskning relatert til hjertekarsykdommer. Medisinsk-juridisk utredning av hjertemedisinske saker. Undervisning og foredragsvirksomhet. Annen relevant næringsvirksomhet.
-legespesialist-tjeneste - hjertesykdommer. -forskning vedrørende spesialist hjertetjeneste.

Keywords

medical practicesspecialists

Organization

CEO
PA

Per Anton Sirnes1954

Chairman of the board
PA

Per Anton Sirnes1954

Years since formation
31 years
since Feb 19, 1995
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
100,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2025
1,240,077
NOK
Annual total result 2025
326,680
NOK
Total equity 2025
4,010,721
NOK
Last update: Oct 8, 2026

Management

Management / administration

NameRoleShares
PA

Per Anton Sirnes

1954

Managing Director/CEO-

Board

NameRoleShares
PA

Per Anton Sirnes

1954

Chairman-
HE

Heidi Elisabeth Granholt Sirnes

1954

Board Member-
EH

Even Harry Rønvik

1948

Board Member-
HK

Helena Kristin Rønvik

1955

Alternate Member-

Others

NameRoleShares
E
ECIT FORRETNINGSPARTNER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
AS

Anton Sirnes Per

1954

-
100 %
directly
Last update: Apr 1, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
AS

Anton Sirnes Per

1954

Ordinary shares
100,000
100 %

Shares owned by the KARDIOKONSULT AS

NameShare classTotal number of sharesShare
S
SIMLOGIC SPV AS
Ordinary shares
10,000
0.54 %
I
IMMUVERA THERAPEUTICS AS
Ordinary shares
25,000
0.38 %
C
CHILLOUT AS
Under liquidation
Ordinary shares
110,000
0.37 %
V
VINO PIEMONTE AS
Ordinary shares
14,700
0.34 %
T
TRILOBITE INDUSTRI AS
Ordinary shares
45,000
0.27 %
E
EQON AS
Ordinary shares
26
0.24 %
F
FISKHER AS
Ordinary shares
900
0.16 %
P
PHARMASUM THERAPEUTICS AS
Ordinary shares
4,000
0.12 %
S
SEABED SEPARATION AS
Class B shares
300
0.11 %
O
OCEAN GEOLOOP ASA
Ordinary shares
50,000
0.09 %
A
ALOTTA AS
Ordinary shares
85,000
0.08 %
G
GLEX AS
Ordinary shares
7,000
0.08 %
V
VIKING ARM MEDICAL AS
Ordinary shares
80
0.06 %
H
HAVKRAFT AS
Ordinary shares
500
0.06 %
I
INSULIFE AS
Ordinary shares
30,000
0.04 %
A
AUGE GROUP AS
Ordinary shares
2,325
0.02 %
A
ATLANTIC SAPPHIRE ASA
Ordinary shares
1,270
< 0.01 %
A
ARENDALS FOSSEKOMPANI ASA
Ordinary shares
100
< 0.01 %
N
NRC GROUP ASA
Ordinary shares
2,500
< 0.01 %
O
ORKLA ASA
Ordinary shares
400
< 0.01 %
G
GREENSTAT AS
Ordinary shares
4,000
< 0.01 %
O
OKEA ASA
Ordinary shares
2,000
< 0.01 %
S
STOREBRAND ASA
Ordinary shares
800
< 0.01 %
H
HEXAGON PURUS ASA
Ordinary shares
3,000
< 0.01 %
V
VÅR ENERGI ASA
Ordinary shares
600
< 0.01 %
T
TEKNA HOLDING ASA
Ordinary shares
20
< 0.01 %
N
NORSE ATLANTIC ASA
Ordinary shares
2,000
< 0.01 %
O
ODFJELL SE
Ordinary shares
200
< 0.01 %
H
HEXAGON COMPOSITES ASA
Ordinary shares
13,000
< 0.01 %
N
NORCONSULT ASA
Ordinary shares
2,000
< 0.01 %
L
LERØY SEAFOOD GROUP ASA
Ordinary shares
500
< 0.01 %
T
TORGHATTEN AQUA AS
Ordinary shares
1,000
< 0.01 %
G
GIGANTE SALMON AS
Ordinary shares
3,000
< 0.01 %
A
AKASTOR ASA
Ordinary shares
3,000
< 0.01 %
A
AKER BP ASA
Ordinary shares
200
< 0.01 %
A
AIRTHINGS AS
Ordinary shares
10,000
< 0.01 %
T
THOR MEDICAL ASA
Ordinary shares
30,000
< 0.01 %
C
CIRCIO HOLDING ASA
Ordinary shares
525
< 0.01 %
Z
ZELLUNA ASA
Ordinary shares
200
< 0.01 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
1,240,077
2,687,350
1,727,499
2,771,150
1,340,236
Annual Total Result
326,680
448,689
216,294
462,607
268,325
Total assets
4,422,123
4,286,006
4,509,304
4,585,921
4,153,086
Total liabilities
411,402
319,965
291,952
384,863
214,634
Total equity
4,010,721
3,966,041
4,217,352
4,201,058
3,938,451

P&L

Year20252024202320222021
Total operating income
1,240,077
2,687,350
1,727,499
2,771,150
1,340,236
Total operating costs
890,452
2,108,343
1,789,132
1,934,160
1,242,405
Operating result
349,625
579,007
-61,633
836,990
97,831
Financial income/costs
124,532
-5,827
296,202
-131,727
206,096
Profit before tax
474,157
573,180
234,569
705,263
303,926
Total tax & extraordinary income/cost
147,477
124,491
18,275
242,656
35,601
Annual Total Result
326,680
448,689
216,294
462,607
268,325

Balance overview

Year20252024202320222021
Total fixed assets
0
69,904
431,404
919,400
1,678,200
Total current assets
4,422,123
4,216,102
4,077,900
3,666,522
2,474,886
Total assets
4,422,123
4,286,006
4,509,304
4,585,921
4,153,086
Short term debt
367,850
265,935
191,080
230,550
76,358
Long term debt
0
0
0
0
0
Total liabilities
411,402
319,965
291,952
384,863
214,634
Contributed capital
100,000
100,000
100,000
100,000
100,000
Retained earnings
3,910,721
3,866,041
4,117,352
4,101,058
3,838,451
Total equity
4,010,721
3,966,041
4,217,352
4,201,058
3,938,451
Total equity and liabilities
4,422,123
4,286,006
4,509,304
4,585,921
4,153,086

Classification

21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.2
Main industrial group
Medical and dental practice activities
86.22
Industrial group
Specialist medical practice activities
86.221
Industrial group
Physicians, specialists other than psychiatrists